Outlook Therapeutics (OTLK) Capital Expenditures (QoQ) (2015 - 2019)
Outlook Therapeutics (OTLK) Capital Expenditures (QoQ) (2015 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Outlook Therapeutics |
51.56 Mn |
43.81 Mn |
-21,888.00 |
| Date | Value |
|---|
| Sep 30, 2019 |
-180.21% |
| Jun 30, 2019 |
1,419.30% |
| Mar 31, 2019 |
-78.79% |
| Dec 31, 2018 |
-81.28% |
| Sep 30, 2018 |
651.56% |
| Jun 30, 2018 |
-38.94% |
| Mar 31, 2018 |
-74.40% |
| Dec 31, 2017 |
4,383.50% |
| Sep 30, 2017 |
-87.30% |
| Jun 30, 2017 |
222.72% |
| Mar 31, 2017 |
182.58% |
| Dec 31, 2016 |
-93.69% |
| Sep 30, 2016 |
-27.42% |
| Jun 30, 2016 |
1,063.76% |
| Mar 31, 2016 |
-112.89% |
| Dec 31, 2015 |
-88.94% |
| Sep 30, 2015 |
-5.58% |
